Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
This study is currently recruiting participants.
Verified December 2012
by Stanford University
Study NCT01163526 Information provided by Stanford University
First Received on July 14, 2010. Last Updated on December 10, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuroendocrine Tumors
Brain (Nervous System) Cancers
Colon/Rectal Cancer
Colon Cancer
Hepatobiliary Cancers
Hepatocellular Carcinoma (Hepatoma)
Liver
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Hepatocellular
Colonic Neoplasms
Rectal Neoplasms
More general conditions related to this trial
Adenocarcinoma
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Rectal Diseases
Interventions listed in this trial
CT perfusion
Sponsors listed in this trial
Stanford University
Siemens Healthcare Sector
GE Healthcare
Back to top of Main Content
